OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhostUNIVERSITÄT DORTMUND

Select item for more details and to access through your institution.

Venetoclax based combination therapy does not overcome poor outcomes in BTKi‐refractory mantle cell lymphoma: phase 2 trial of umbralisib, ublituximab, and venetoclax.
Published in:
Hematological Oncology, 2023, v. 41, p. 484, doi. 10.1002/hon.3164_356
By:
- Wallace, D. S.;
- Rowland, C.;
- Hill, B. T.;
- Baran, A. M.;
- Casulo, C.;
- Reagan, P. M.;
- Winter, A.;
- Karmali, R.;
- Winter, J. N.;
- Gordon, L. I.;
- Bui, A.;
- Sportelli, P.;
- Weiss, M. S.;
- Miskin, H. P.;
- Friedberg, J. W.;
- Ma, S.;
- Barr, P. M.
Publication type:
Article
Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study.
Published in:
Hematological Oncology, 2023, v. 41, p. 416, doi. 10.1002/hon.3164_306
By:
- Hu, B.;
- Reagan, P. M.;
- Sehn, L. H.;
- Sharman, J.;
- Hertzberg, M.;
- Zhang, H.;
- Kim, A.;
- Herbaux, C.;
- Molina, L.;
- Maruyama, D.;
- Smolewski, P.;
- Stenner, F.;
- Craine, V.;
- Kothari, R.;
- Hirata, J.;
- Sahin, D.;
- Sugidono, M.;
- Lee, C.;
- Tilly, H.
Publication type:
Article